Filter
2242
Filtered Results: 2242
Text search:
Drug
Safety
Monitoring
Programme
Featured
Recommendations
253
New Publications
712
Language
Document type
No document type
1345
Guidelines
329
Studies & Reports
286
Manuals
120
Strategic & Response Plan
105
Training Material
24
Fact sheets
18
Situation Updates
8
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
157
Kenya
77
Global
67
South Africa
64
Nigeria
59
Uganda
54
Nepal
48
Sierra Leone
46
Tanzania
45
Western and Central Europe
44
Ghana
41
Zambia
38
Myanmar / Burma
37
Ethiopia
36
Malawi
35
Bangladesh
31
Liberia
31
Namibia
27
Africa
25
Lesotho
19
Eastern Europe
19
South–East Asia Region
18
Rwanda
16
Zimbabwe
16
Cambodia
15
Asia
14
Latin America and the Carribbean
13
Botswana
13
Ukraine
12
Syria
12
Philippines
12
Congo, Democratic Republic of
10
Indonesia
10
Russia
8
Tajikistan
7
Cameroon
7
South Sudan
7
Eswatini/ Swaziland
7
Albania
6
Senegal
6
West and Central Africa
6
Western Pacific Region
6
Eastern Europe and Central Asia
6
East and Southern Africa
6
Pakistan
6
Thailand
5
Burkina Faso
5
Middle East and North Africa
5
Laos
4
Guinea
4
Mozambique
4
Afghanistan
3
Germany
3
Sudan
3
Georgia
3
Iraq
3
Benin
2
China
2
Kyrgyzstan
2
USA
2
Haiti
2
United Kingdom
2
Brazil
2
Sri Lanka
2
Bhutan
2
Somalia
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
El Salvador
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Singapore
1
Uzbekistan
1
Peru
1
Qatar
1
Bulgaria
1
Lithuania
1
Jordan
1
Ireland
1
Paraguay
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Lebanon
1
Vietnam
1
Moldova
1
Yemen
1
Central African Republic
1
Poland
1
Honduras
1
Angola
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
920
Clinical Guidelines
234
Public Health
143
Key Resources
105
Women & Child Health
104
Pharmacy & Technologies
40
Capacity Building
35
Toolboxes
HIV
254
TB
194
AMR
147
Mental Health
131
COVID-19
76
Pharmacy
75
NTDs
74
Caregiver
53
Rapid Response
48
NCDs
44
Ebola & Marburg
38
Planetary Health
33
Global Health Education
29
Conflict
28
Disability
24
Refugee
22
Health Financing Toolbox
11
Polio
11
Natural Hazards
10
Cholera
9
Specific Hazards
8
Zika
5
Malaria
2
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Framework for implementation.
The END TB Strategy.
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Confronted with the important issue of patient safety, in 2002 the Fifty-fifth World Health Assembly adopted a resolution urging countries to pay the closest possible attention to the problem and to strengthen safety and monitoring systems. In May 2004, the Fifty-seventh World Health Assembly approv...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
Therapeutics Information and Pharmacovigilance Centre | TIPC
UNAIDS/WHO Working group
HIV/AIDS and STI surveillance 2015 / Reference
